Allergan (AGN) Forms New IBS CounSEL
- Wall St slips as higher yields offset upbeat corporate earnings
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- Boeing reports first revenue drop in 7 quarters as deliveries decline
- Oil prices fall as U.S. business activity cools, concerns over Middle East ease
- Yen on the brink, but Tesla pulls back
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Hasbro (HAS) brand strength sees earnings top expectations
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Wolfe Research Downgrades Warner Brothers Discovery (WBD) to Underperform, 'out of concern that an incipient advertising downturn put guidance at risk'
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
Allergan Demonstrates Ongoing Commitment to Irritable Bowel Syndrome (IBS) with Development of IBS CounSEL
October 16, 2016 8:01 AM EDTDUBLIN, Oct. 16, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today the formation of the IBS CounSEL, a group of multidisciplinary experts dedicated to improving diagnosis and management of irritable bowel syndrome (IBS) by providing Support, Education and Leadership (SEL) to physicians and allied healthcare professionals. The IBS CounSEL will launch their new website at the American College of Gastroenterology (ACG) Annual Scientific Meeting from October 14-19, 2016 in Las Vegas.
Logo -... More